SuperSonic Imagine SA (SSI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SuperSonic Imagine SA (SSI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6604
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuperSonic Imagine SA (SuperSonic) is a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers ultrasound system, aixplorer that finds clinical applications in breast, abdomen, liver, vascular, musculoskeletal, pediatrics, prostate, vascular, gyneacology, obstetrics and thyroid. It offers services such as protection plan, technical support, remote service and maintenance. SuperSonic develops UltraFast platform technologies used to acquire images in conventional ultrasound systems. The company also has collaboration with financial, academic institute, and public and private organizations. It operates in France, Germany, the US and the UK. SuperSonic is headquartered in Aix-en-Provence, France.

SuperSonic Imagine SA (SSI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuperSonic Imagine SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SuperSonic Imagine SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SuperSonic Imagine SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SuperSonic Imagine SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SuperSonic Imagine SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SuperSonic Imagine SA, Medical Equipment, Deal Details 10
Venture Financing 10
SuperSonic Imagine Raises US$6.8 Million In Venture Financing Round 10
Supersonic Imagine Raises Us$36 Million In Series D Financing 11
Partnerships 13
SuperSonic Imagine Enters into Distribution Agreement with Sandhill Scientific 13
Unetixs Vascular Enters into Distribution Agreement with SuperSonic Imagine 14
SuperSonic Imagine Enters into Distribution Agreement with Konica Minolta for Aixplorer in Japan 15
Equity Offering 16
SuperSonic Imagine Raises USD11 Million in Rights Offering of Shares 16
SuperSonic Imagine Completes IPO For US$69 Million 18
Acquisition 19
Shanghai United Imaging Healthcare May Acquire Supersonic Imagine 19
SuperSonic Imagine SA – Key Competitors 20
SuperSonic Imagine SA – Key Employees 21
SuperSonic Imagine SA – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Sep 11, 2018: Supersonic Imagine announces its results for the first half of 2018 23
Jul 18, 2018: SuperSonic Imagine announces +11% sales growth in Q2 and +15% in h1 2018 at constant currency 25
Apr 18, 2018: SuperSonic Imagine Reports Q1 2018 Revenue Growth of +11% 26
Mar 13, 2018: SuperSonic Imagine Announces its 2017 Results 27
Jan 24, 2018: SuperSonic Imagine Announces 2017 Sales Growth of +11% to €24.7 Million (+13% Constant Currency) 29
Sep 12, 2017: SuperSonic Imagine Announces Its Results for the First Half of 2017 30
Jul 19, 2017: SuperSonic Imagine Announces +16% Sales Growth In Q2 And +16% Over H1 2017 32
Apr 20, 2017: SuperSonic Imagine Announces Q1 2017 Revenue Growth of +16% 33
Jan 25, 2017: SuperSonic Imagine Reports 2016 Sales Growth of +11% to €22.2 Million 34
Other Significant Developments 35
Oct 18, 2017: SuperSonic Imagine Reports Sales Growth of +13% in Q3 2017 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
SuperSonic Imagine SA, Medical Equipment, Key Facts, 2017 2
SuperSonic Imagine SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SuperSonic Imagine SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SuperSonic Imagine SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SuperSonic Imagine SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SuperSonic Imagine SA, Deals By Market, 2012 to YTD 2018 8
SuperSonic Imagine SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SuperSonic Imagine Raises US$6.8 Million In Venture Financing Round 10
Supersonic Imagine Raises Us$36 Million In Series D Financing 11
SuperSonic Imagine Enters into Distribution Agreement with Sandhill Scientific 13
Unetixs Vascular Enters into Distribution Agreement with SuperSonic Imagine 14
SuperSonic Imagine Enters into Distribution Agreement with Konica Minolta for Aixplorer in Japan 15
SuperSonic Imagine Raises USD11 Million in Rights Offering of Shares 16
SuperSonic Imagine Completes IPO For US$69 Million 18
Shanghai United Imaging Healthcare May Acquire Supersonic Imagine 19
SuperSonic Imagine SA, Key Competitors 20
SuperSonic Imagine SA, Key Employees 21
SuperSonic Imagine SA, Other Locations 22
SuperSonic Imagine SA, Subsidiaries 22

List of Figures
SuperSonic Imagine SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SuperSonic Imagine SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SuperSonic Imagine SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SuperSonic Imagine SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SuperSonic Imagine SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SuperSonic Imagine SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SuperSonic Imagine SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SuperSonic Imagine SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SuperSonic Imagine SA (SSI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teledyne Technologies Incorporated (TDY)-石油・ガス分野:企業M&A・提携分析
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of instrumentation, digital imaging products and software, aerospace and defense electronics and engineered systems. The company provides electronic subsystems, monitoring instrumentation for marine and environmental applications, h …
  • Contact Energy Ltd (CEN):企業の財務・戦略的SWOT分析
    Contact Energy Ltd (CEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes bio-generic drugs and vaccines to treat autoimmune diseases and cancer. The company’s product portfolio includes TrabiDHA, a vegetarian source of DHA (Docosahexaenoic acid), used to manufacture healt …
  • Schweiter Technologies AG (SWTQ):企業の財務・戦略的SWOT分析
    Summary Schweiter Technologies AG (Schweiter) is a technology company that develops, manufactures and commercialize composite panels and core materials for sandwich constructions. The company’s business category includes core materials, architecture, display and transportation. It SSM textile machin …
  • Emerson Electric Co (EMR):企業の財務・戦略的SWOT分析
    Emerson Electric Co (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company’s manufactures products for analgesic and antipyretic, antibiotic, anticoagulant, disinfectant and antiseptic, iron supplement, neurology, …
  • Crescita Therapeutics Inc (CTX)-製薬・医療分野:企業M&A・提携分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • CH&Co Group:企業の戦略・SWOT・財務分析
    CH&Co Group - Strategy, SWOT and Corporate Finance Report Summary CH&Co Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution …
  • Ithaca Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Ithaca Energy Inc. (Ithaca), a subsidiary of Delek Group Ltd., is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset po …
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Zoomlion Heavy Industry Science and Technology Co., Ltd.:企業の戦略・SWOT・財務情報
    Zoomlion Heavy Industry Science and Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Zoomlion Heavy Industry Science and Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • Beltrami Electric Cooperative Inc:企業の戦略的SWOT分析
    Beltrami Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Lorain-Medina Rural Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Lorain-Medina Rural Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Hewlett Packard Enterprise Company (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Company (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • Southwestern Energy Co (SWN):企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cytune Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Cytune Pharma SAS (Cytune) is a developer of immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decreases metastasis numbers, tumor …
  • KT&G Corp:企業の戦略・SWOT・財務情報
    KT&G Corp - Strategy, SWOT and Corporate Finance Report Summary KT&G Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆